Seiwert TY - Search Results

1

Poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancer.

Heitmann J, Geeleher P, Zuo Z, Weichselbaum RR, Vokes EE, Fetscher S, Seiwert TY. Heitmann J, et al. Among authors: seiwert ty. Oral Oncol. 2014 Sep;50(9):825-31. doi: 10.1016/j.oraloncology.2014.06.004. Epub 2014 Jul 10. Oral Oncol. 2014. PMID: 25017803

2

State-of-the-art management of locally advanced head and neck cancer.

Seiwert TY, Cohen EE. Seiwert TY, et al. Br J Cancer. 2005 Apr 25;92(8):1341-8. doi: 10.1038/sj.bjc.6602510. Br J Cancer. 2005. PMID: 15846296 Free PMC article. Review.

3

A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.

Seiwert TY, Connell PP, Mauer AM, Hoffman PC, George CM, Szeto L, Salgia R, Posther KE, Nguyen B, Haraf DJ, Vokes EE. Seiwert TY, et al. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):515-22. doi: 10.1158/1078-0432.CCR-06-1058. Clin Cancer Res. 2007. PMID: 17255273 Clinical Trial.

4

The concurrent chemoradiation paradigm--general principles.

Seiwert TY, Salama JK, Vokes EE. Seiwert TY, et al. Nat Clin Pract Oncol. 2007 Feb;4(2):86-100. doi: 10.1038/ncponc0714. Nat Clin Pract Oncol. 2007. PMID: 17259930 Review.

5

The chemoradiation paradigm in head and neck cancer.

Seiwert TY, Salama JK, Vokes EE. Seiwert TY, et al. Nat Clin Pract Oncol. 2007 Mar;4(3):156-71. doi: 10.1038/ncponc0750. Nat Clin Pract Oncol. 2007. PMID: 17327856 Review.

6

Chemoradiotherapy for locally advanced head and neck cancer.

Salama JK, Seiwert TY, Vokes EE. Salama JK, et al. Among authors: seiwert ty. J Clin Oncol. 2007 Sep 10;25(26):4118-26. doi: 10.1200/JCO.2007.12.2697. J Clin Oncol. 2007. PMID: 17827462 Review. No abstract available.

7

A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer.

Seiwert TY, Cohen EE, Haraf DJ, Stenson K, Blair EA, Mauer A, Dekker A, Vokes EE. Seiwert TY, et al. Cancer Invest. 2007 Sep;25(6):435-44. doi: 10.1080/07357900701357993. Cancer Invest. 2007. PMID: 17882655 Clinical Trial.

8

Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion.

Jagadeeswaran R, Surawska H, Krishnaswamy S, Janamanchi V, Mackinnon AC, Seiwert TY, Loganathan S, Kanteti R, Reichman T, Nallasura V, Schwartz S, Faoro L, Wang YC, Girard L, Tretiakova MS, Ahmed S, Zumba O, Soulii L, Bindokas VP, Szeto LL, Gordon GJ, Bueno R, Sugarbaker D, Lingen MW, Sattler M, Krausz T, Vigneswaran W, Natarajan V, Minna J, Vokes EE, Ferguson MK, Husain AN, Salgia R. Jagadeeswaran R, et al. Among authors: seiwert ty. Cancer Res. 2008 Jan 1;68(1):132-42. doi: 10.1158/0008-5472.CAN-07-1998. Cancer Res. 2008. PMID: 18172305 Free PMC article.

9

Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.

Seiwert TY, Haraf DJ, Cohen EE, Stenson K, Witt ME, Dekker A, Kocherginsky M, Weichselbaum RR, Chen HX, Vokes EE. Seiwert TY, et al. J Clin Oncol. 2008 Apr 1;26(10):1732-41. doi: 10.1200/JCO.2007.13.1706. J Clin Oncol. 2008. PMID: 18375903 Clinical Trial.

10

Targeting angiogenesis in head and neck cancer.

Seiwert TY, Cohen EE. Seiwert TY, et al. Semin Oncol. 2008 Jun;35(3):274-85. doi: 10.1053/j.seminoncol.2008.03.005. Semin Oncol. 2008. PMID: 18544442 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

137 results

Search Page